Is there evidence for late cognitive decline in chronic schizophrenia?

Psychiatric Quarterly

Volumn 83, Issue 2, 2012, Pages 127-144

  Shah, Jharna N ^a   Qureshi, Salah U ^a,b   Jawaid, Ali ^c   Schulz, Paul E ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cognitive decline; Cognitive deficits; Cognitive impairment; Dementia; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E; NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEMENTIA; EARLY ONSET SCHIZOPHRENIA; EDUCATION; FAMILY HISTORY; FOLLOW UP; GENOTYPE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LATE ONSET SCHIZOPHRENIA; MINI MENTAL STATE EXAMINATION; REVIEW; SCHIZOPHRENIA;

AGE FACTORS; AGE OF ONSET; CHRONIC DISEASE; COGNITION DISORDERS; DATABASES, BIBLIOGRAPHIC; DEMENTIA; DISEASE PROGRESSION; HUMANS; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84863988677     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-011-9189-8     Document Type: Review

References (52)

1. Schizophrenia-U.S. Department of Health and Human Services, National Institutes of Health National Institute of Mental Health NIH Publication No. 09-3517 Revised 2009
2. Barbato A: Schizophrenia and Public health. Nations for Mental Health. WHO/MSA/NAM/97.6, 1998
3. Asarnow RF: Neurocognitive impairments in schizophrenia: A piece of the epigenetic puzzle. European Child & Adolescent Psychiatry 8(Suppl 1):I5-8, 1999
4. Ciompi L: Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin 6(4):606-618, 1980
5. de Vries PJ, Honer WG, Kemp PM et al.: Dementia as a complication of schizophrenia. Journal of Neurology, Neurosurgery & Psychiatry 70(5):588-596, 2001
6. Banaschewski T, Schulz E, Martin M, Remschmidt H: Cognitive functions and psychopathological symptoms in early-onset schizophrenia. European Child & Adolescent Psychiatry 9(1):11-20, 2000
7. Kørner A, Lopez AG, Lauritzen L et al.: Late and very-late first-contact schizophrenia and the risk of dementia\-a nationwide register based study. International Journal ofGeriatric Psychiatry 24:61-67, 2009
8. Brodaty H, Sachdev P, Koschera A, et al.: Long-term outcome of late-onset schizophrenia: 5-year follow-up study. The British Journal of Psychiatry 183:213-219, 2003
9. Rabins PV, Lavrisha M: Long-term follow-up and phenomenologic differences distinguish among late-onset schizophrenia, late-life depression, and progressive dementia. American Journal of Geriatric Psychiatry 11:6, 2003.
10. Goldberg TE, Hyde TM, Kleinman JE, et al.: Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophrenia Bulletin 19:797-804, 1993
11. Lieberman JA: Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biological Psychiatry 46(6):729-739, 1999
12. Farmer ME, Kittner SJ, Rae DS, et al.: Education and change in cognitive function. The Epidemiologic Catchment Area Study. Annals of Epidemiology 5:1-7, 1995
13. Corral M, Rodríguez M, Amenedo E et al. Cognitive reserve, age, and neuropsychological performance in healthy participants. Developmental Neuropsychology 29(3):479-491, 2006
14. Cohn T, Prud'homme D, Streiner D et al.: Characterizing coronary heart disease risk in chronic schizophrenia: High prevalence of the metabolic syndrome. Canadian Journal of Psychiatry 49(11):753-660, 2004
15. Stahl SM, Mignon L, Meyer JM: Which comes first: Atypical antipsychotic treatment or cardioembolic risk? Acta Psychiatrica Scandinavica. 119(3):171-179, 2009
16. Lin HC, Hsiao FH, Pfeiffer S, et al.: An increased risk of stroke among young schizophrenia patients. Schizophrenia Research 101(1-3):234-241, 2008
17. Malaspina D, Goetz RR, Friedman JH, et al.: Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees. The American Journal of Psychiatry 158:440-446, 2001
18. Dean B, Laws SM, Hone E, et al.: Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biological Psychiatry 54(6):616-622, 2003
19. Schürhoff F, Krebs MO, Szöke A, et al.: ApolipoproteinEinschizophrenia:AFrench association study and meta-analysis. American JournalofMedical Genetics B:Neuropsychiatric Genetics 119B (1):18-23, 2003
20. Hata T, Kunugi H, Nanko S, et al.: Possible effect of the APOE epsilon 4 allele on the hippocampal volume and asymmetry in schizophrenia. American Journal of Medical Genetics 114(6):641-642, 2002
21. Jeste DV, Gladsjo JA, Lindamer LA, et al.: Medical comorbidities in Schizophrenia. Schizophrenia Bulletin 22(3):413-430, 1996
22. Niizato K, Genda K, Nakamura R, et al.: Cognitive decline in schizophrenics with AD a mini-review of neuropsychological and neuropathological studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry 25:1359-1366, 2001
23. Ortakov V, Mancevski B, Keilp J, et al.: Application of cognitive scales to medical records of schizophrenia inpatients. Schizophrenia Research 35(2):131-140, 1999
24. CERAD: CERAD 1986-1996, Documentation and Data. Archive Rev 1.0, March 1996. Durham, NC, 1996
25. Friedman JI, Harvey PD, Coleman T, et al.: Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: A comparison with Alzheimer's disease and normal aging. The American Journal of Psychiatry 158(9):1441-1448, 2001
26. Raven JC: Standard Progressive Matrices. London, Lewis, 1958a
27. Raven JC: The Mill Hill Vocabulary Scale. London, Lewis, 1958b
28. Morrison G, O'Carroll R, McCreadie R: Long-term course of cognitive impairment in schizophrenia. The British Journal of Psychiatry 189:556-557, 2006
29. Waddington JL, Youssef HA: Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine 26(4):681-688, 1996
30. Harvey PD, Silverman JM, Mohs RC, et al.: Cognitive decline in late-life schizophrenia: A longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry 45(1):32-40, 1999
31. Harvey PD, Parrella M, White L, et al.: Convergence of cognitive and adaptive decline in late-life schizophrenia. Schizophrenia Research 35(1):77-84, 1999
32. Friedman JI, Harvey PD, McGurk SR, et al.: Correlates of change in functional status of institutionalized geriatric schizophrenic patients: Focus on medical comorbidity. The American Journal of Psychiatry 159(8):1388-1394, 2002
33. Harvey PD, Bertisch H, Friedman JI, et al.: The course of functional decline in geriatric patients with schizophrenia: Cognitive-functional and clinical symptoms as determinants of change. American Journal of Geriatric Psychiatry 11(6):610-619, 2003
34. Meagher DJ, Quinn JF, Bourke S, et al.: Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population. Psychiatry Research 126(3):217-227, 2004
35. Chemerinski E, Reichenberg A, Kirkpatrick B, et al.: Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status. Schizophrenia Research 85(1-3):12-19, 2006
36. White L, Friedman JI, Bowie CR, et al.: Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: Retrospective comparison of first generation and second generation anti-psychotics. Schizophrenia Research 88(1-3):127-134, 2006
37. Nayak Savla G, Moore DJ, Roesch SC, et al.: An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: Use of mixed-model analyses. Schizophrenia Research 83(2-3):215-223, 2006
38. Harvey PD, White L, Parrella M, et al.: The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one-and two-year follow-ups in geriatric in-patients. The British Journal of Psychiatry 166(5):630-633, 1995
39. Harvey PD, Lombardi J, Leibman M, et al.: Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: A follow-up study. Schizophrenia Research 22(3):223-231, 1996
40. Harvey PD, Lombardi J, Leibman M, et al.: Performance of chronic schizophrenia patients on cognitive neuropsychological measures sensitive to dementia. International Journal of Geriatric Psychiatry 11:621-627, 1996
41. McGurk SR, Moriarty PJ, Harvey PD, et al.: The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophrenia Research 42(1):47-55, 2000
42. Laks J, Fontenelle LF, Chalita A, et al.: Absence of dementia in late-onset schizophrenia: A one year follow-up of a Brazilian case series. Arq Neuropsiquiatr 64(4):946-949, 2006
43. Heaton RK, Gladsjo JA, Palmer BW, et al.: Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry 58(1):24-32, 2001
44. Palmer BW, Bondi MW, Twamley EW, et al.: Are late-onset schizophrenia spectrum disorders neu-rodegenerative conditions? Annual rates of change on two dementia measures. The Journal of Neu-ropsychiatry and Clinical Neurosciences 15(1):45-52, 2003
45. Lewis R: Should cognitive deficit be a diagnostic criterion for schizophrenia? Journal of Psychiatry & Neuroscience 29(2):102-113, 2004
46. Waddington JL, Youssef HA, Dolphin C, et al.: Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Archives of General Psychiatry 44(10):907-912, 1987
47. Liddle PF, Crow TJ.: Age disorientation in chronic schizophrenia is associated with global intellectual impairment. The British Journal of Psychiatry 144:193-199, 1984
48. Spohn HE, Strauss ME: Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology 98(4):367-380, 1989
49. Goldberg TE, Weinberger DR: Effects of neuroleptic medications on the cognition of patients with schizophrenia: A review of recent studies. Journal of Clinical Psychiatry 57(Suppl 9):62-65, 1996
50. Galderisi S, Davidson M, Kahn RS, et al.: Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study. Schizophrenia Research, 2009
51. Chen EY, Lam LC, Chen RY, et al.: Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia. The British Journal of Psychiatry 168:227-233, 1996
52. Norman RM, Malla AK, Morrison-Stewart SL, et al.: Neuropsychological correlates of syndromes in schizophrenia. The British Journal of Psychiatry 170:134-139, 1997